Clinical features and outcomes of pediatric intracranial gliomas: results from single center’s 226 cases and corroborated with SEER database
Tóm tắt
Pediatric gliomas are the most common central nervous system (CNS) tumors in children and adolescents and show different clinical and histopathological characteristics from the adult. The prognostic factors were poorly defined in pediatric intracranial gliomas. We collected pediatric intracranial glioma cases in our institution between February 2011 and June 2022. The patient clinical data, tumor growth characteristics, treatments, and follow-up data were analyzed by Cox regression analysis to identify impact factors on the prognosis of pediatric intracranial glioma patients. To corroborate our data, an independent cohort of pediatric intracranial glioma from the Surveillance, Epidemiology, and End Results Program (SEER) database was analyzed. A total of 181 cases of pediatric low-grade glioma (PLGG) and 45 cases of pediatric high-grade glioma (PHGG) were included. In multivariate Cox regression analysis, tumor size > 59.5 mm (p = 0.006) and non-gross total resection (non-GTR; subtotal resection, STR, p = 0.042; biopsy, p = 0.012) were associated with decreased overall survival (OS) in PLGG patients. In PHGG patients, only chemotherapy (p = 0.023) was associated with OS while tumor size was marginally prognostic for OS (p = 0.051). Additional independent analysis of 2734 PLGG and 741 PHGG from the SEER database corroborated that larger tumor size was associated with decreased OS in LGG (p = 0.001) and HGG (p < 0.001) patients, separately. In this study, we found that tumor size was a significant prognostic factor for the OS of PLGG patients in our series. Besides the tumor size, the extent of resection also independently impacted the prognosis of PLGG patients. While in PHGG patients, only chemotherapy was associated with improved OS and tumor size was marginally prognostic.
Tài liệu tham khảo
Sturm D, Pfister SM, Jones DTW (2017) Pediatric gliomas: current concepts on diagnosis, biology, and clinical management. J Clin Oncol : Official J Am Soc Clin Oncol 35(21):2370–2377
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncology
Pfister SM, Reyes-Múgica M, Chan JKC, Hasle H, Lazar AJ, Rossi S et al (2022) A summary of the inaugural WHO classification of pediatric tumors: transitioning from the optical into the molecular era. Cancer Discov 12(2):331–355
Varlet P, Le Teuff G, Le Deley MC, Giangaspero F, Haberler C, Jacques TS et al (2020) WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial. Neuro Oncol 22(1):116–127
Gilles FH, Brown WD, Leviton A, Tavaré CJ, Adelman L, Rorke LB et al (2000) Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium Cancer 88(6):1477–1483
Boudaouara O, Charfi S, Bahri M, Daoud J, Boudawara MZ, Gouiaa N et al (2019) Pediatric high grade gliomas: clinico-pathological profile, therapeutic approaches and factors affecting overall survival. Neurochirurgie 65(2–3):63–68
Wen J, Chen W, Zhu Y, Zhang P (2021) Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis. BMC Cancer 21(1):81
Alattar AA, Brandel MG, Hirshman BR, Dong X, Carroll KT, Ali MA et al (2018) Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis. J Neurosurg 128(4):1076–1083
Ai X, Liao X, Li J, Tang P, Jiang J (2020) Clinical outcomes of N3 breast cancer: a real-world study of a single institution and the US Surveillance, Epidemiology, and End Results (SEER) Database. Cancer Manag Res 12:5331–5343
Miller KD, Ostrom OT, Kruchko C, Patil N, Tihan T, Cioffi G et al (2021) Brain and other central nervous system tumor statistics, 2021. CA: Cancer J Clin 71(5):381–406
Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro-oncology 23(12 Suppl 2):iii1–iii105
Espinoza JC, Haley K, Patel N, Dhall G, Gardner S, Allen J et al (2016) Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: final report of the Head Start II and III trials. Pediatr Blood Cancer 63(10):1806–1813
Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR et al (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol : Official J Am Soc Clin Oncol 13(1):112–123
Wolff JE, Gnekow AK, Kortmann RD, Pietsch T, Urban C, Graf N et al (2002) Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94(1):264–271
Jalali R, Rishi A, Goda JS, Sridhar E, Gurav M, Sharma P et al (2016) Clinical outcome and molecular characterization of pediatric glioblastoma treated with postoperative radiotherapy with concurrent and adjuvant temozolomide: a single institutional study of 66 children. Neuro-oncol Pract 3(1):39–47
Azizi AA, Paur S, Kaider A, Dieckmann K, Peyrl A, Chocholous M et al (2018) Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma?. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al] 194(6):552–559
Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA et al (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neuro-oncol 7(2):165–77
Jung TY, Lee JY, Kim DS, Park HJ, Kim CY, Ra YS et al (2015) Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology. J Neurooncol 121(2):413–419
Napieralska A, Krzywon A, Mizia-Malarz A, Sosna-Zielińska J, Pawłowska E, Krawczyk MA et al (2021) High-grade gliomas in children-a multi-institutional Polish study. Cancers 13(9)
Shaw EG, Wisoff JH (2003) Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro Oncol 5(3):153–160
Pignatti F, Van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol : Official J Am Soc Clin Oncol 20(8):2076–2084
Maxwell R, Luksik AS, Garzon-Muvdi T, Yang W, Huang J, Bettegowda C et al (2018) Population-based study determining predictors of cancer-specific mortality and survival in pediatric high-grade brainstem glioma. World neurosurg 119:e1006–e1015
Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR et al (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children’s Oncology Group. J Clin Oncol : Official J Am Soc Clin Onc 30(21):2641–2647
Bartlett A, Lane A, Chaney B, Escorza NY, Black K, Cochrane A et al (2022) Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry. Neuro Oncol 24(12):2190–2199
Erker C, Lane A, Chaney B, Leary S, Minturn JE, Bartels U et al (2022) Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry. Neuro Oncol 24(1):141–152
Metzger S, Weiser A, Gerber NU, Otth M, Scheinemann K, Krayenbühl N et al (2022) Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes. J Neurooncol 157(2):307–317
Hidalgo ET, Kvint S, Orillac C, North E, Dastagirzada Y, Chang JC et al (2019) Long-term clinical and visual outcomes after surgical resection of pediatric pilocytic/pilomyxoid optic pathway gliomas. J Neurosurg Pediatr 24(2):166–173
Garzón M, García-Fructuoso G, Suñol M, Mora J, Cruz O (2015) Low-grade gliomas in children: single institutional experience in 198 cases. Child’s Nerv Syst : ChNS : Official J Int Soc Pediatr Neurosurg 31(9):1447–1459
Liu H, Chen Y, Qin X, Jin Z, Jiang Y, Wang Y (2022) Epidemiology and survival of patients with optic pathway gliomas: a population-based analysis. Front Oncol 12:789856
Qaddoumi I, Sultan I, Gajjar A (2009) Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database. Cancer 115(24):5761–5770